Literature DB >> 26456528

Genome-wide inactivation of porcine endogenous retroviruses (PERVs).

Luhan Yang1, Marc Güell2, Dong Niu3, Haydy George4, Emal Lesha4, Dennis Grishin4, John Aach4, Ellen Shrock4, Weihong Xu5, Jürgen Poci4, Rebeca Cortazio4, Robert A Wilkinson6, Jay A Fishman6, George Church1.   

Abstract

The shortage of organs for transplantation is a major barrier to the treatment of organ failure. Although porcine organs are considered promising, their use has been checked by concerns about the transmission of porcine endogenous retroviruses (PERVs) to humans. Here we describe the eradication of all PERVs in a porcine kidney epithelial cell line (PK15). We first determined the PK15 PERV copy number to be 62. Using CRISPR-Cas9, we disrupted all copies of the PERV pol gene and demonstrated a >1000-fold reduction in PERV transmission to human cells, using our engineered cells. Our study shows that CRISPR-Cas9 multiplexability can be as high as 62 and demonstrates the possibility that PERVs can be inactivated for clinical application of porcine-to-human xenotransplantation.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2015        PMID: 26456528     DOI: 10.1126/science.aad1191

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  178 in total

1.  Xenotransplantation makes a comeback.

Authors:  Jeffrey M Perkel
Journal:  Nat Biotechnol       Date:  2016-01       Impact factor: 54.908

2.  Getting rid of PERVs.

Authors:  Irene Jarchum
Journal:  Nat Biotechnol       Date:  2016-01       Impact factor: 54.908

Review 3.  Interspecies chimeric complementation for the generation of functional human tissues and organs in large animal hosts.

Authors:  Jun Wu; Juan Carlos Izpisua Belmonte
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

Review 4.  Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.

Authors:  Jing Yao; Jiaojiao Huang; Jianguo Zhao
Journal:  Hum Genet       Date:  2016-07-18       Impact factor: 4.132

5.  An effective vaginal gel to deliver CRISPR/Cas9 system encapsulated in poly (β-amino ester) nanoparticles for vaginal gene therapy.

Authors:  Gang Niu; Zhuang Jin; Chong Zhang; Dan He; Xueqin Gao; Chenming Zou; Wei Zhang; Jiahui Ding; Bhudev C Das; Konstantin Severinov; Inga Isabel Hitzeroth; Priya Ranjan Debata; Xin Ma; Xun Tian; Qinglei Gao; Jun Wu; Zeshan You; Rui Tian; Zifeng Cui; Weiwen Fan; Weiling Xie; Zhaoyue Huang; Chen Cao; Wei Xu; Hongxian Xie; Hongyan Xu; Xiongzhi Tang; Yan Wang; Zhiying Yu; Hui Han; Songwei Tan; Shuqin Chen; Zheng Hu
Journal:  EBioMedicine       Date:  2020-07-22       Impact factor: 8.143

Review 6.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

Review 7.  Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models.

Authors:  Narumi Uno; Satoshi Abe; Mitsuo Oshimura; Yasuhiro Kazuki
Journal:  J Hum Genet       Date:  2017-11-27       Impact factor: 3.172

8.  Rise of the Pigs: Utilization of the Porcine Model to Study Musculoskeletal Biomechanics and Tissue Engineering During Skeletal Growth.

Authors:  Stephanie G Cone; Paul B Warren; Matthew B Fisher
Journal:  Tissue Eng Part C Methods       Date:  2017-09-01       Impact factor: 3.056

Review 9.  Can We Re-Engineer the Endocrine Pancreas?

Authors:  Antonio Citro; Harald C Ott
Journal:  Curr Diab Rep       Date:  2018-10-02       Impact factor: 4.810

Review 10.  Xenotransplantation: past, present, and future.

Authors:  Burcin Ekser; Ping Li; David K C Cooper
Journal:  Curr Opin Organ Transplant       Date:  2017-12       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.